SV2009003251A - Acido l-glutamico marcado con ( f-18), l-glutamina marcada con (f-18), sus derivados y su uso, asi como procedimientos para su preparacion - Google Patents
Acido l-glutamico marcado con ( f-18), l-glutamina marcada con (f-18), sus derivados y su uso, asi como procedimientos para su preparacionInfo
- Publication number
- SV2009003251A SV2009003251A SV2009003251A SV2009003251A SV2009003251A SV 2009003251 A SV2009003251 A SV 2009003251A SV 2009003251 A SV2009003251 A SV 2009003251A SV 2009003251 A SV2009003251 A SV 2009003251A SV 2009003251 A SV2009003251 A SV 2009003251A
- Authority
- SV
- El Salvador
- Prior art keywords
- marked
- glutamic acid
- derivatives
- glutamine
- procedures
- Prior art date
Links
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 title abstract 5
- 229960002989 glutamic acid Drugs 0.000 title abstract 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/04—Nickel compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
SE DESCRIBEN LOS COMPUESTOS Y LA SÍNTESIS DE ÁCIDO L-GLUTÁMICO MARCADO CON [F-18], L-GLUTAMATO MARCADO CON [F-18], SUS DERIVADOS DE ACUERDO CON LA FORMULA (I) Y SUS USOS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2006138584/04A RU2395489C2 (ru) | 2006-11-01 | 2006-11-01 | [f-18] меченная l-глютаминовая кислота, [f-18] меченный l-глютамин, их производные и их применение, а также способ их получения |
EP06090211A EP1923382A1 (de) | 2006-11-18 | 2006-11-18 | [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2009003251A true SV2009003251A (es) | 2009-12-15 |
Family
ID=38896929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2009003251A SV2009003251A (es) | 2006-11-01 | 2009-04-30 | Acido l-glutamico marcado con ( f-18), l-glutamina marcada con (f-18), sus derivados y su uso, asi como procedimientos para su preparacion |
Country Status (24)
Country | Link |
---|---|
US (2) | US20100217011A1 (es) |
EP (1) | EP2086924B1 (es) |
JP (4) | JP5529540B2 (es) |
KR (1) | KR101495924B1 (es) |
CN (1) | CN101595083B (es) |
AR (1) | AR071043A1 (es) |
AU (1) | AU2007315203B2 (es) |
BR (1) | BRPI0718055A2 (es) |
CA (1) | CA2667395C (es) |
CL (2) | CL2007003169A1 (es) |
CO (1) | CO6180453A2 (es) |
CU (1) | CU23825B1 (es) |
EA (1) | EA017713B1 (es) |
EC (1) | ECSP099304A (es) |
ES (1) | ES2701423T3 (es) |
HK (1) | HK1138568A1 (es) |
IL (1) | IL198022A0 (es) |
MX (1) | MX2009004686A (es) |
NO (1) | NO20092123L (es) |
NZ (1) | NZ576582A (es) |
PE (1) | PE20091723A1 (es) |
SV (1) | SV2009003251A (es) |
TW (1) | TWI415626B (es) |
WO (1) | WO2008052788A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2123621A1 (de) | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
KR101495924B1 (ko) * | 2006-11-01 | 2015-02-25 | 바이엘 파마 악티엔게젤샤프트 | [f-18]-표지된 l-글루탐산, [f-18]-표지된 l-글루타민, 이들의 유도체 및 이들의 용도 및 이들의 제조 방법 |
EP2123620A1 (en) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them |
EP2123619A1 (de) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma AG | Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
KR101756793B1 (ko) | 2008-10-10 | 2017-07-11 | 메르크 앤드 씨에 | Pet 방사성트레이서로서의 18f-표지화된 엽산 |
US8722014B2 (en) * | 2009-05-01 | 2014-05-13 | Washington University | 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof |
SG178393A1 (en) | 2009-08-14 | 2012-03-29 | Univ Pennsylvania | Single diastereomers of 4-fluoroglutamine and methods fo their preparation and use |
EP2322171A3 (en) * | 2009-11-17 | 2011-06-01 | Bayer Schering Pharma Aktiengesellschaft | Fluorine labeled L-glutamic acid derivatives |
US20130034497A1 (en) * | 2009-11-17 | 2013-02-07 | Piramal Imaging Sa | Iodine-labeled homoglutamic acid and glutamic acid derivatives |
EP2501663A2 (en) * | 2009-11-17 | 2012-09-26 | Piramal Imaging SA | Method for production of f-18 labeled glutamic acid derivatives |
EP2338892A1 (en) * | 2009-12-18 | 2011-06-29 | Bayer Schering Pharma Aktiengesellschaft | Prostate specific membrane antigen inhibitors |
US9139316B2 (en) | 2010-12-29 | 2015-09-22 | Cardinal Health 414, Llc | Closed vial fill system for aseptic dispensing |
EP2520556A1 (en) | 2011-05-03 | 2012-11-07 | Bayer Pharma Aktiengesellschaft | Radiolabeled amino acids for diagnostic imaging |
EP2520557A1 (en) | 2011-05-03 | 2012-11-07 | Bayer Pharma Aktiengesellschaft | Novel precursors of glutamate derivatives |
WO2013012822A1 (en) | 2011-07-15 | 2013-01-24 | Cardinal Health 414, Llc | Systems, methods, and devices for producing, manufacturing, and control of radiopharmaceuticals |
US20130020727A1 (en) | 2011-07-15 | 2013-01-24 | Cardinal Health 414, Llc. | Modular cassette synthesis unit |
US20130022525A1 (en) * | 2011-07-15 | 2013-01-24 | Cardinal Health 414, Llc | Methods and compositions for drying in the preparation of radiopharmaceuticals |
US9417332B2 (en) | 2011-07-15 | 2016-08-16 | Cardinal Health 414, Llc | Radiopharmaceutical CZT sensor and apparatus |
WO2020010228A1 (en) * | 2018-07-06 | 2020-01-09 | The Regents Of The University Of California | Deconstructive functionalization methods and compounds |
CN109369445B (zh) * | 2018-11-20 | 2021-10-15 | 首都医科大学 | 用于诊断和治疗的放射性谷氨酰胺衍生物及其制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1461184A (fr) * | 1964-12-23 | 1966-01-07 | Takeda Chemical Industries Ltd | Procédé de préparation d'isoxazolidones substituées en position 5 |
DE1620522A1 (de) * | 1964-12-23 | 1970-04-23 | Takeda Chemical Industries Ltd | Verfahren zur Herstellung von 5-substituierten Isoxazolidonverbindungen |
US5264570A (en) * | 1992-08-05 | 1993-11-23 | General Electric Company | Method for making 2-[18 F]fluoro-2-deoxy-D-glucose |
US5267570A (en) * | 1992-12-30 | 1993-12-07 | Preston Myra S | Method of diagnosing and treating chronic fatigue syndrome |
GB9324872D0 (en) | 1993-12-03 | 1994-01-19 | Univ Pasteur | Pharmaceutical compounds |
MXPA01009893A (es) * | 1999-04-01 | 2003-07-28 | Esperion Therapeutics Inc | Compuestos con eter, composiciones y usos de estos. |
WO2002014261A2 (en) | 2000-08-10 | 2002-02-21 | Eli Lilly And Company | 4-substituted d-glutamic acid derivatives for use as antibiotic |
WO2002018941A2 (en) | 2000-09-01 | 2002-03-07 | Annovis, Inc. | Screen for glutamate reuptake inhibitors, stimulators, and modulators |
DE10223451A1 (de) * | 2002-05-25 | 2003-12-24 | Abx Gmbh | Verfahren zur Herstellung von 18F-fluorierten alpha-Aminosäuren |
PL375183A1 (en) | 2002-08-02 | 2005-11-28 | Mallinckrodt Inc. | Radioactively labelled amino acid analogues, their preparation and use |
DE10346228B4 (de) * | 2003-09-25 | 2009-04-09 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Herstellung von [18F]fluormarkierten aromatischen L-Aminosäuren |
US7270799B2 (en) * | 2004-01-15 | 2007-09-18 | Nst Neurosurvival Technologies Ltd. | Perturbed membrane-binding compounds and methods of using the same |
US7483732B2 (en) * | 2004-04-15 | 2009-01-27 | Boston Scientific Scimed, Inc. | Magnetic resonance imaging of a medical device and proximate body tissue |
US20070011016A1 (en) * | 2005-07-07 | 2007-01-11 | Alderman Joseph B | Springing interests flowing from benefits that run with land |
KR101495924B1 (ko) | 2006-11-01 | 2015-02-25 | 바이엘 파마 악티엔게젤샤프트 | [f-18]-표지된 l-글루탐산, [f-18]-표지된 l-글루타민, 이들의 유도체 및 이들의 용도 및 이들의 제조 방법 |
EP1923382A1 (de) | 2006-11-18 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung |
EP2123621A1 (de) | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
EP2123620A1 (en) | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them |
EP2123619A1 (de) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma AG | Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
-
2007
- 2007-10-30 KR KR20097009017A patent/KR101495924B1/ko active IP Right Grant
- 2007-10-30 ES ES07819544T patent/ES2701423T3/es active Active
- 2007-10-30 EP EP07819544.3A patent/EP2086924B1/de active Active
- 2007-10-30 NZ NZ576582A patent/NZ576582A/en not_active IP Right Cessation
- 2007-10-30 CA CA2667395A patent/CA2667395C/en not_active Expired - Fee Related
- 2007-10-30 CN CN200780040971.7A patent/CN101595083B/zh not_active Expired - Fee Related
- 2007-10-30 JP JP2009535027A patent/JP5529540B2/ja not_active Expired - Fee Related
- 2007-10-30 US US12/513,112 patent/US20100217011A1/en not_active Abandoned
- 2007-10-30 EA EA200970428A patent/EA017713B1/ru not_active IP Right Cessation
- 2007-10-30 WO PCT/EP2007/009518 patent/WO2008052788A1/de active Application Filing
- 2007-10-30 BR BRPI0718055-1A2A patent/BRPI0718055A2/pt not_active IP Right Cessation
- 2007-10-30 MX MX2009004686A patent/MX2009004686A/es active IP Right Grant
- 2007-10-30 AU AU2007315203A patent/AU2007315203B2/en not_active Ceased
- 2007-11-01 AR ARP070104863A patent/AR071043A1/es not_active Application Discontinuation
- 2007-11-01 TW TW096141249A patent/TWI415626B/zh not_active IP Right Cessation
- 2007-11-02 CL CL200703169A patent/CL2007003169A1/es unknown
-
2008
- 2008-04-23 PE PE2008000696A patent/PE20091723A1/es not_active Application Discontinuation
-
2009
- 2009-04-06 IL IL198022A patent/IL198022A0/en unknown
- 2009-04-30 SV SV2009003251A patent/SV2009003251A/es unknown
- 2009-04-30 CO CO09043963A patent/CO6180453A2/es not_active Application Discontinuation
- 2009-04-30 EC EC2009009304A patent/ECSP099304A/es unknown
- 2009-05-04 CU CU20090072A patent/CU23825B1/es not_active IP Right Cessation
- 2009-05-29 NO NO20092123A patent/NO20092123L/no not_active Application Discontinuation
-
2010
- 2010-05-28 HK HK10105265.5A patent/HK1138568A1/xx not_active IP Right Cessation
-
2012
- 2012-03-28 CL CL2012000768A patent/CL2012000768A1/es unknown
-
2013
- 2013-12-02 JP JP2013249417A patent/JP5815651B2/ja not_active Expired - Fee Related
- 2013-12-02 JP JP2013249418A patent/JP2014088389A/ja active Pending
-
2014
- 2014-01-13 US US14/153,491 patent/US9375497B2/en active Active
- 2014-06-10 JP JP2014119836A patent/JP5749836B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2009003251A (es) | Acido l-glutamico marcado con ( f-18), l-glutamina marcada con (f-18), sus derivados y su uso, asi como procedimientos para su preparacion | |
SV2010003739A (es) | Nuevos derivados de acido l-glutamico y l-glutamina marcados con [f-18] (i), su uso y procedimiento para su preparacion | |
CR20110610A (es) | Nuevos derivados de pirimidina y sus usos en el tratamiento del cáncer y otras enfermedades | |
ECSP077271A (es) | Derivados de pirimidina | |
UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
ECSP077259A (es) | Derivados de pirimidina | |
CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
ECSP11011181A (es) | Compuestos orgánicos | |
ECSP11011185A (es) | Compuestos orgánicos | |
UY31093A1 (es) | Compuestos de ariloazol-2-il cianoetilamino, método para prepararlos y método para utilizarlos | |
UY32383A (es) | Dionas cíclicas herbicidamente activas, derivados, procesos para su preparación composiciones que las comprenden y usos de las mismas | |
UY31905A (es) | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
AR075892A1 (es) | Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
ECSP12011651A (es) | Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato | |
SV2007002315A (es) | Derivados de octahidropirrolo[3,4-c]pirrol ref. pc32623a | |
CO6351723A2 (es) | Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de crf1 | |
UY31836A (es) | Nuevo ácido l-glurámico marcado con [f-18] y derivados de l-glutamina marcada con [f-18] (ii), su uso y procedimientos para su preparación | |
DOP2010000155A (es) | Derivados de pirazol como inhibidores de 5-lo | |
UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
GT200600305A (es) | Métodos para preparar derivados de acido glutamico | |
ECSP099679A (es) | Nuevos compuestos y sus usos 707 | |
GT200600153A (es) | Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios. | |
ECSP088933A (es) | Métodos para preparar derivados de ácido glutámico y sus intermedios | |
UY30683A1 (es) | Acido l-glutamico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, asi como procedimientos para su preparacion. | |
DOP2009000098A (es) | Ácido l-glutamico marcado con [f-18], l-glutamina marcada con [f-18], sus derivados y su uso, así como procedimientos para su preparación |